Vásquez-Lastra C, Castro-Gaytán A, Cisneros B, Contreras A, Mérigo J, Ochoa G, Bonilla M

Language: Spanish
References: 18
Page: 278-282
PDF size: 136.79 Kb.

ABSTRACT

Objective: We present our experience with photoselective vaporization (PVP) of the prostate by KTP laser for symptomatic benign prostatic hyperplasia reporting the efficacy and safety as well as clinical outcomes of the procedure.
Materials and methods: From June 2006 to January 2008 a total of 150 patients with symptomatic and obstructive benign prostatic hyperplasia were treated with an 80 W potassium-titanyl-phosphate laser. Preoperative evaluation included digital rectal examination (DRE), American Urological Association Symptom Index (AUASI) score, quality of life score (QOL), peak urinary flow rate (Qmax), post-void residual urine volume (PVR) and suprapubic ultrasound prostate volume measurement. Patients were evaluated at 1, 3, 6 and 12 months following treatment. At each follow up evaluation, side effects and efficacy parameters were measured.
Results: Mean lasing time was 72.7 minutes and mean prostate volume was 72 ml. There was no significant blood loss or fluid absorption during or immediately after PVP. Significant improvements in AUA-SI score, QOL score, Qmax and PVR were noted as early as 1 month after PVP treatment. At 12 months the mean AUA-SI score decreased from 11.8 to 3.2 (70% improvement) and the Qmax increased from 6.75 to 19.7 ml per second (191% improvement). PVR decreased from 336 to 25 ml (92.5% improvement). No major complications were noted.
Conclusions: PVP is a safe and effective outpatient procedure with low morbidity and excellent long term results. In our experience, results are seen as soon as 1 month after surgery and persist through follow-up.

REFERENCES

1. Kabalin JN, Bite G, Doll S. Neodymium: YAG laser coagulation prostatectomy: 3 years of experience with 227 patients. J Urol 1996;155(1):181-185.

2. Tooher R, Sutherland P, Costello A. A systemic review of holmium laser prostatectomy for benign prostatic hyperplasia. J Urol 2004;171(5): 1773-81.

3. Malek RS, Kuntzman RS, Barrett DM. High-power potassium-titanyl-phosphate laser vaporization prostatectomy. J Urol 2000;163(6):1730-33.

4. Wojcik M, Dennison D. Photoselective vaporization of the prostate in ambulatory surgery. AORN J 2006;83(2):330-4.

5. Arum CJ, Romundstat P. Photoselective vaporization of the prostate utilizing local anesthesia for the treatment of symptomatic prostatic obstruction: a report of 150 cases. Eur Urol (Suppl) 2006;5(2):235.

6. Bachmann A, Ruzsat R, Wyler S, Reich O, Seiffert HH, Muller A, Sulser T. Photoselective vaporization of the prostate: the basel experience after 108 procedures. Eur Urol 2005;47(6):798-804.

7. Malloy TR. Emerging high-power KTP laser applications in urology. Contemp Urol 2007;17(2):30-37.

8. Ruszat R, Wyler S, Forster T, Reich O, Stief CG, Gasser TC, Sulser T. Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation. Eur Urol 2007;51(4):1031-8.

9. Fu WJ, Hong BF, Wang XX, Yang Y, Cai W, Gao JP, Chen YF, Zhang CE. Evaluation of greenlight photoselective vaporization of the prostate for the treatment of high-risk patients with benign prostatic hyperplasia. Asian J Androl 2006;8(3):367-71.

10. Sandhu JS, Ng CK, Gonzalez RR, Kaplan SA, Te AE. Photoselective laser vaporization prostatectomy in men receiving anticoagulants. J Endourol 2005;19(10):1196-98.

11. Reich O, Bachmann A, Siebels M, Hofstetter. A High Power (80 W) Potassium-Titanyl-Phosphate Laser Vaporization of the Prostate in 66 High Risk patients. J Urol 2005;173(1):158-160.

12. Kemal S, Erdal A. Photoselective Vaporization of the enlarged prostate with KTP laser: long-term results in 240 patients. J Endourol 2005;19(10):199-1202.

13. Reza S. Malek, Randall S. Kuntzman, David M. Barret. Photoselective potassium-titanyl-phosphate laser vaporization of the benign obstructive prostate: Observation on long-term outcomes. J Urol 2005;174(4 pt 1)1344-8.

14. Volkan T, Ihsan TA, Yilmaz O, Emin O. Short term outcomes of high power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate. Eur Urol 2005;48(4):608-13.

15. Alexis E. Te, Terrence R. Malloy, Barry S. Stein. Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multi-center prospective trial. J Urol 2004;172(4):1404-08.

16. Malek RS, Kuntzman RS, Barrett DM. High-Power potassium-titanyl-phosphate laser vaporization prostatectomy. J Urol 2000;163(6):1730-33.

17. Chandrasekera S. Muir G. Curr. Potassium titanyl phosphate laser prostatectomy: a review. Opin Urol 2007;17(1):22-6.

18. Bachmann A, Schürch L, Ruszat R. Photoselective Vaporization (PVP) versus Transurethral Resection of the Prostate (TURP): A prospective Bi-Centre study of perioperative morbidity and early functional outcome. Eur Urol 2005;48(6):965-71.